Technologies
PDF


WARF: P130298US01

Monitoring Tissue Fluorescence in Bright Light


INVENTORS -

Thomas (Rock) Mackie, Adam Uselmann, Andreas Velten, Surendra Prajapati, Kevin Eliceiri

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing a fluorescence imaging system that can detect faint signals in brightly lit surgical suites.
OVERVIEWIntrinsic and extrinsic fluorescent markers can help surgeons target and rapidly identify tumorous tissue. The signals given off by these markers are relatively faint and normally viewed with a fluorescent microscope or wide-field camera. Special imaging mechanisms isolate and boost the signals for detection.

While the markers simplify and improve tumor identification by “lighting up” otherwise invisible clusters of fluorescently labeled (e.g., cancerous) cells in both biopsies and surgery, the ambient room-lighting of the surgical suite must be turned off or greatly attenuated during surgery in order to detect the signals of many fluorescent markers, interrupting the workflow of the entire team.

Another application of intraoperative fluorescence imaging is locating embedded blood vessels or nervous tissue, which is useful in a variety of procedures. Depending on the emitted wavelength, the sensitivity of these techniques is limited by light contamination from the surroundings.
THE INVENTIONUW–Madison researchers have developed a fluorescence imaging process that can be used in surgical suites and other brightly lit environments. Specifically, the imaging process coordinates with rapidly switched ambient room light, which turns off and on at a speed imperceptible to the human eye. Alternatively, research locations such as bioimaging facilities that are traditionally dark can be illuminated – improving productivity and safety. During the periods of darkness, fluorescence signals from microscopes can be detected and imaged without background light interference.
APPLICATIONS
  • Medical tissue fluorescence
  • Intrinsic fluorescence contrast
  • In vivo animal imaging
  • Research tissue imaging
KEY BENEFITS
  • Faint signals can be detected and monitored in the operating room.
  • Compatible with standard fluorescence systems
STAGE OF DEVELOPMENTPreliminary work has demonstrated a capture duty cycle of 90 percent combined with 500 Hz room illumination at a 5 percent duty cycle. The capture duty cycle may be extended further, to more than 99 percent. This would mean that detector sensitivity would only drop by 1 percent compared to a perfectly dark room while using full room illumination.
Contact Information
For current licensing status, please contact Jeanine Burmania at jeanine@warf.org or 608-960-9846.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.